The Centers for Disease Control and Prevention has released a list of all facilities that recently purchased products from New England Compounding Center.

CDC is urging health care providers to contact all patients who received any type of injectable from the manufacturer since May.

Steroid injections from the Massachusett’s company have been linked to a deadly nationwide fungal meningitis outbreak.

There are seven Miami Valley health care providers on the list of 64 facilities provided to the Ohio Department of Health.

The list includes any provider who bought a NECC product since May 21, even topical products, which the Food and Drug Administration has indicated are low or no-risk products for fungal meningitis.

“At this point they are being on the extremely cautious side,” said Public Health - Dayton & Montgomery County spokesman Bill Wharton.

He said the local health department is working with ODH to contact local providers on the list and make sure they are aware of which products have been recalled and then letting those providers handle any patient contacts or questions.

“At this time, ODH does not have a count on the number of patients that received drugs in the expanded recall list. Since this investigation is changing so rapidly, it’s critical that Ohioans who received these injections or solutions be informed and watch closely for any change in how they are feeling,” said ODH Director, Ted Wymyslo.

ODH said in a statement Tuesday that they used a statewide health emergency alerting system to contact health care providers and hospitals throughout the state with this additional guidance from the FDA. Local health departments are being tasked with calling each facility in their jurisdiction and supporting those facilities with patient outreach. ODH expects every patient who received a recalled injection to be contacted, the statement said.

Most of the local providers on the list could not be reached for comment Tuesday evening.

Good Samaritan Hospital operates the Samaritan North Surgery Center and Communications Manager Renee Roberts said the center only purchased one repackaged product, an intravenous contrast agent, from NECC earlier this year. She said that product is, “not in any way related to the compounds involved in the meningitis outbreak.”

Wharton said anyone with questions or concerns should contact their physician.

There have been 233 cases nationwide and 15 deaths, according to the CDC.

Ohio currently has seven cases of fungal meningitis, which can not be spread from person to person, all linked to back injections with steroids distributed by NECC. There have been no deaths in Ohio.

If you receive steroid shots for back or joint pain, are you concerned you’re at risk for contracting fungal meningitis? Have you contacted your health-care provider for information? Several health-care providers in the Dayton region received medications prepared by a Massachusetts pharmacy, New England Compounding Center, linked to a deadly outbreak, and they’re being told to pull those products, including injectable steroids for treating back or joint pain, off the shelves. If you’re worried you’re at risk, please contact Dayton Daily News reporter Peggy O’Farrell at 937-225-7457 or peggy.ofarrell@coxinc.com to share your story.